Searched for
VENKAT KRISHNAN
Stocks in news: HUL, Bajaj Finance, Suzlon Energy, Federal Bank, Gensol EngineeringDomestic markets closed lower on Monday with Reliance Industries and Kotak Bank under pressure. HUL and Bajaj Finance to announce Q1 result...
RBI clears KVS Manian's appointment as MD & CEO of Federal BankThe bank stated that Krishnan Venkat Subramanian (KVS) will join the bank on September 23, 2024, a day after Shyam Srinivasan ends his term...
RBI approves appointment of former Kotak exec KV Subramanian as CEO & MD of Federal BankThe Reserve Bank of India has approved Krishnan Venkat Subramanian as Managing Director & Chief Executive Officer of Federal Bank. Subraman...
Tamil superstar Thalapathy Vijay wraps up shooting for 'Leo'Bollywood star Sanjay Dutt also stars in 'Leo', which marks his Tamil debut.
Microsoft India president Anant Maheshwari resignsMaheshwari’s exit comes amidst the rejig among top-level executives at the software company. The company’s chief operating officer Irina Gh...
Microsoft India elevates key hands in top-level rejigUS Tech major promotes chief operating officer Irina Ghose as India managing director. The current MD Sashi Sreedharan has been elevated to...
GS Krishnan takes over as new 'ABLE' PresidentGS Krishnan, formerly regional president & MD, Novozymes South Asia Pvt Ltd, a Danish biotech company, has taken charge as the new Presiden...
- Buy Rain Industries Ltd. target Rs 142.0 : Mazhar Mohammad
Buy Rain Industries Ltd. at a price target of Rs 142.0 and a stoploss at Rs 110.0 from entry point
Daan Utsav gets bigger and reaches places in its 8th yearWhile in absolute numbers India leads, the country still ranks low at 106th (out of 145) on the 2015 global index, thanks to the size of it...
Bionpharma buys 25 products from specialty drug maker Banner Life SciencesThe combined revenue of the acquired products is estimated at more than $70 million and forms a mix of high-potency steroidal, antiviral, e...
Former Ranbaxy executives set up their own venture Bion Pharma in USThey will leverage their experience of spearheading the Indian drug maker’s operations as it encountered a series of regulatory setbacks in...
Ranbaxy's US subsidiary sees 5 top-level exits including boss Venkat KrishnanThe changes come within months of Sun Pharmaceutical Industries agreeing to acquire Ranbaxy from Japan’s Daiichi Sankyo under a $4 billion ...
Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India MDToday’s Supreme Court judgment on the Glivec case means that innovator companies like Novartis will see little protection for intellectual ...
- Ranbaxy to relaunch bessling brand
Ranbaxy Laboratories has received US drug regulator's approval to relaunch one of its best selling brand in the US after being banned for n...
- Ranbaxy receives USFDA approval for anti acne drug Absorica
Ranbaxy laboratories has received an approval for an anti acne drug Absorica developed by US firm Cipher, the company said in a release to ...
- Ranbaxy Laboratories launches generic Cadeut in the American market
Drug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Ranbaxy buys rights for 13 dermatology products
Ranbaxy Laboratories on Monday said it has acquired the US marketing rights for 13 dermatology products from Bristol-Myers Squibb Company (...